NCT05297630View on ClinicalTrials.gov

Comparative Evaluation of the Evolution of Emerging Biological Markers in Patients Hospitalized for Acute Heart Failure According to Conventional Management or Therapeutic Adjustment Via Daily Ultrasound.

CompletedOBSERVATIONAL
Enrollment

169

Participants

Timeline

Start Date

February 15, 2022

Primary Completion Date

July 9, 2022

Study Completion Date

July 9, 2022

Conditions
Heart Failure
Interventions
OTHER

Evaluation of the evolution of biological markers from the biobank.

The evolution of sST2, copeptin, chromogranin, NGAL, suPAR and cystatin will be evaluated between Day 0 and Month 1

Trial Locations (2)

30029

Nîmes University Hospital, Nîmes

34295

Montpellier University Hospital, Arnaud de Villeneuve, Montpellier

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER